Page 2 - Conditional Marketing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Conditional Marketing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Conditional Marketing Today - Breaking & Trending Today

Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy

Published: July 21, 2022

- Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication - - Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) in May 2022 - NEWTON, Mass.andFLORENCE, Italy, July 21, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group ("Menarini"), a privately-held, leading international pharmaceutical company, today announced that the European Commission (EC) has granted Marketing Authorisa...

Source: philippinetimes.com

Humanigen, Inc.: Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom

Published: June 16, 2022

Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a late-stage clinical biopharmaceutical company focused on preventing and treating an immune hyper-response called 'cytokine storm,' today announced it entered

Source: finanznachrichten.de

$Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO® (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma - Vimarsana News$

Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO® (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma

Published: May 20, 2022

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group...

Source: prnewswire.com

$Menarini Industrie Farmaceutiche Riunite: Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma - Vimarsana News$

Menarini Industrie Farmaceutiche Riunite: Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma

Published: May 20, 2022

-- European Commission Decision Anticipated within Approximately 60 Days -- NEWTON, Mass. and FLORENCE, Italy, May 20, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI),

Source: finanznachrichten.de

21st Austria weekly - Andritz, Agrana, Valneva (25/04/2022)

Published: May 1, 2022

21st Austria weekly - Andritz Agrana Valneva 25/04/2022 [pic1]Andritz: International technology group Andritz has received an order from Papierfabriek Doetinchem Netherlands to upgrade the wet sections of its PM1 and PM3 special paper machines. The start-ups are scheduled for 2022. aim investment is improve quality provide basis a possible capacity increase. will deliver ModuScreen HB dilution headbox screens PrimeFlow AT headboxes with PrimeProfiler F control pumps both machines.Andritz:

Source: boerse-social.com